S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies von Wagner, Nikolaus B, Forschner, Andrea, Leiter, Ulrike, Garbe, Claus, Eigentler, Thomas K

Volltext

Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomise... von Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C, Fluck, Michael, Eigentler, Thomas K, Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C, Schadendorf, Dirk, Simon, Jan-Christoph, Herbst, Rudolf A, Berking, Carola, Utikal, Jochen, Sell, Sabine, Martens, Uwe M, Terheyden, Patrick, Stadler, Rudolf

Volltext

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects von Garbe, Claus, Eigentler, Thomas K., Keilholz, Ulrich, Hauschild, Axel, Kirkwood, John M.

Volltext

Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study von Eigentler, Thomas K., Leiter, Ulrike, Häfner, Hans-Martin, Garbe, Claus, Röcken, Martin, Breuninger, Helmut

Volltext

Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management von Heinzerling, Lucie, Eigentler, Thomas K, Fluck, Michael, Hassel, Jessica C, Heller-Schenck, Daniela, Leipe, Jan, Pauschinger, Matthias, Vogel, Arndt, Zimmer, Lisa, Gutzmer, Ralf

Volltext

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy von Hofmann, Lars, Forschner, Andrea, Loquai, Carmen, Goldinger, Simone M, Zimmer, Lisa, Ugurel, Selma, Schmidgen, Maria I, Gutzmer, Ralf, Utikal, Jochen S, Göppner, Daniela, Hassel, Jessica C, Meier, Friedegund, Tietze, Julia K, Thomas, Ioannis, Weishaupt, Carsten, Leverkus, Martin, Wahl, Renate, Dietrich, Ursula, Garbe, Claus, Kirchberger, Michael C, Eigentler, Thomas, Berking, Carola, Gesierich, Anja, Krackhardt, Angela M, Schadendorf, Dirk, Schuler, Gerold, Dummer, Reinhard, Heinzerling, Lucie M

Volltext

Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions von Hassel, Jessica C, Heinzerling, Lucie, Aberle, Jens, Bähr, Oliver, Eigentler, Thomas K, Grimm, Marc-Oliver, Grünwald, Victor, Leipe, Jan, Reinmuth, Niels, Tietze, Julia K, Trojan, Jörg, Zimmer, Lisa, Gutzmer, Ralf

Volltext

Melanoma brain metastases – Interdisciplinary management recommendations 2020 von Gutzmer, Ralf, Vordermark, Dirk, Hassel, Jessica C., Krex, Dietmar, Wendl, Christina, Schadendorf, Dirk, Sickmann, Thomas, Rieken, Stefan, Pukrop, Tobias, Höller, Christoph, Eigentler, Thomas K., Meier, Friedegund

Volltext

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab von Martens, Alexander, Wistuba-Hamprecht, Kilian, Geukes Foppen, Marnix, Yuan, Jianda, Postow, Michael A, Wong, Phillip, Romano, Emanuela, Khammari, Amir, Dreno, Brigitte, Capone, Mariaelena, Ascierto, Paolo A, Di Giacomo, Anna Maria, Maio, Michele, Schilling, Bastian, Sucker, Antje, Schadendorf, Dirk, Hassel, Jessica C, Eigentler, Thomas K, Martus, Peter, Wolchok, Jedd D, Blank, Christian, Pawelec, Graham, Garbe, Claus, Weide, Benjamin

Volltext

What causes the death of patients with cutaneous squamous cell carcinoma? A prospective analysis in 1400 patients von Eigentler, Thomas K., Dietz, Klaus, Leiter, Ulrike, Häfner, Hans-Martin, Breuninger, Helmut

Volltext

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial von Ribas, Antoni, Prof, Puzanov, Igor, MD, Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Hamid, Omid, MD, Robert, Caroline, Prof, Hodi, F Stephen, MD, Schachter, Jacob, Prof, Pavlick, Anna C, MD, Lewis, Karl D, MD, Cranmer, Lee D, MD, Blank, Christian U, MD, O'Day, Steven J, MD, Ascierto, Paolo A, Prof, Salama, April K S, MD, Margolin, Kim A, Prof, Loquai, Carmen, MD, Eigentler, Thomas K, MD, Gangadhar, Tara C, MD, Carlino, Matteo S, MBBS, Agarwala, Sanjiv S, Prof, Moschos, Stergios J, MD, Sosman, Jeffrey A, Prof, Goldinger, Simone M, MD, Shapira-Frommer, Ronnie, MD, Gonzalez, Rene, Prof, Kirkwood, John M, Prof, Wolchok, Jedd D, Prof, Eggermont, Alexander, Prof, Li, Xiaoyun Nicole, PhD, Zhou, Wei, PhD, Zernhelt, Adriane M, BS, Lis, Joy, BSN, Ebbinghaus, Scot, MD, Kang, S Peter, MD, Daud, Adil, Prof

Volltext

Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant... von Garbe, Claus, Keim, Ulrike, Amaral, Teresa, Berking, Carola, Eigentler, Thomas K, Flatz, Lukas, Gesierich, Anja, Leiter, Ulrike, Stadler, Rudolf, Sunderkötter, Cord, Tüting, Thomas, Utikal, Jochen, Wollina, Uwe, Zimmer, Lisa, Zouboulis, Christos C, Ascierto, Paolo A, Eggermont, Alexander M M, Grob, Jean-Jacques, Hauschild, Axel, Sekulovic, Lidija Kandolf, Long, Georgina V, Luke, Jason J, Michielin, Olivier, Peris, Ketty, Schadendorf, Dirk, Kirkwood, John M, Lorigan, Paul C

Volltext

Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts von Garbe, Claus, Keim, Ulrike, Suciu, Stefan, Amaral, Teresa, Eigentler, Thomas K, Gesierich, Anja, Hauschild, Axel, Heinzerling, Lucie, Kiecker, Felix, Schadendorf, Dirk, Stadler, Rudolf, Sunderkötter, Cord, Tüting, Thomas, Utikal, Jochen, Wollina, Uwe, Zouboulis, Christos C, Keilholz, Ulrich, Testori, Alessandro, Martus, Peter, Leiter, Ulrike, Eggermont, Alexander M M

Volltext

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition von Heppt, Markus V., Heinzerling, Lucie, Kähler, Katharina C., Forschner, Andrea, Kirchberger, Michael C., Loquai, Carmen, Meissner, Markus, Meier, Friedegund, Terheyden, Patrick, Schell, Beatrice, Herbst, Rudolf, Göppner, Daniela, Kiecker, Felix, Rafei-Shamsabadi, David, Haferkamp, Sebastian, Huber, Margit A., Utikal, Jochen, Ziemer, Mirjana, Bumeder, Irmgard, Pfeiffer, Christiane, Schäd, Susanne G., Schmid-Tannwald, Christoph, Tietze, Julia K., Eigentler, Thomas K., Berking, Carola

Volltext

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma von Amaral, Teresa M.S., Hoffmann, Marie-Christine, Sinnberg, Tobias, Niessner, Heike, Sülberg, Heiko, Eigentler, Thomas K, Garbe, Claus

Volltext

Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients von WEIDE, Benjamin, PASCOLO, Steve, SCHEEL, Birgit, DERHOVANESSIAN, Evelyna, PFLUGFELDER, Annette, EIGENTLER, Thomas K, PAWELEC, Graham, HOERR, Ingmar, RAMMENSEE, Hans-Georg, GARBE, Claus

Volltext

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network von Voskens, Caroline J, Goldinger, Simone M, Loquai, Carmen, Robert, Caroline, Kaehler, Katharina C, Berking, Carola, Bergmann, Tanja, Bockmeyer, Clemens L, Eigentler, Thomas, Fluck, Michael, Garbe, Claus, Gutzmer, Ralf, Grabbe, Stephan, Hauschild, Axel, Hein, Rüdiger, Hundorfean, Gheorghe, Justich, Armin, Keller, Ullrich, Klein, Christina, Mateus, Christine, Mohr, Peter, Paetzold, Sylvie, Satzger, Imke, Schadendorf, Dirk, Schlaeppi, Marc, Schuler, Gerold, Schuler-Thurner, Beatrice, Trefzer, Uwe, Ulrich, Jens, Vaubel, Julia, von Moos, Roger, Weder, Patrik, Wilhelm, Tabea, Göppner, Daniela, Dummer, Reinhard, Heinzerling, Lucie M

Volltext

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders von Kähler, Katharina C., Eigentler, Thomas K., Gesierich, Anja, Heinzerling, Lucie, Loquai, Carmen, Meier, Friedegund, Meiss, Frank, Pföhler, Claudia, Schlaak, Max, Terheyden, Patrick, Thoms, Kai M., Ziemer, Mirjana, Zimmer, Lisa, Gutzmer, Ralf

Volltext

Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma von Meckbach, Diana, Bauer, Jürgen, Pflugfelder, Annette, Meier, Friedegund, Busch, Christian, Eigentler, Thomas K, Capper, David, von Deimling, Andreas, Mittelbronn, Michel, Perner, Sven, Ikenberg, Kristian, Hantschke, Markus, Büttner, Petra, Garbe, Claus, Weide, Benjamin

Volltext

Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours von Brenner, Ellen, Schörg, Barbara F., Ahmetlić, Fatima, Wieder, Thomas, Hilke, Franz Joachim, Simon, Nadine, Schroeder, Christopher, Demidov, German, Riedel, Tanja, Fehrenbacher, Birgit, Schaller, Martin, Forschner, Andrea, Eigentler, Thomas, Niessner, Heike, Sinnberg, Tobias, Böhm, Katharina S., Hömberg, Nadine, Braumüller, Heidi, Dauch, Daniel, Zwirner, Stefan, Zender, Lars, Sonanini, Dominik, Geishauser, Albert, Bauer, Jürgen, Eichner, Martin, Jarick, Katja J., Beilhack, Andreas, Biskup, Saskia, Döcker, Dennis, Schadendorf, Dirk, Quintanilla-Martinez, Leticia, Pichler, Bernd J., Kneilling, Manfred, Mocikat, Ralph, Röcken, Martin

Volltext